Lymphocyte modulation by tofacitinib in patients with rheumatoid arthritis

Tofacitinib is an oral small molecule targeting the intracellular Janus kinase–signal transducer and activator of transcription (JAK‐STAT) pathways approved for the treatment of active rheumatoid arthritis (RA). We investigated the effects of tofacitinib on the response of RA lymphocytes to B and T...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Clin Exp Immunol
मुख्य लेखकों: Isailovic, Natasa, Ceribelli, Angela, Cincinelli, Gilberto, Vecellio, Matteo, Guidelli, Giacomo, Caprioli, Marta, Luciano, Nicoletta, Motta, Francesca, Selmi, Carlo, De Santis, Maria
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: John Wiley and Sons Inc. 2021
विषय:
ORIGINAL ARTICLES
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC8274203/
https://ncbi.nlm.nih.gov/pubmed/33899926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13609
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन